CITA Biomedical Licenses UROD Treatment to Grant's Hospital.Business/Health Editors BEVERLY HILLS, Calif.--(BUSINESS WIRE)--Nov. 29, 2000 CITA CITA Committee for the Implementation of Textile Agreements CITA Canadian Institute for Theoretical Astrophysics CITA Center for Information Technology Accommodation (US; now the GSA IT Accommodation Division) Biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :DTOX) a growing leader in the treatment of addiction dependency, today announced that it has signed an agreement with Chicago's Grant Hospital, who will license CITA's U.S. patented Ultra Rapid Opiate opiate /opi·ate/ (o´pe-it) 1. any drug derived from opium. 2. hypnotic (2). o·pi·ate n. 1. Detoxification Detoxification Definition Detoxification is one of the more widely used treatments and concepts in alternative medicine. It is based on the principle that illnesses can be caused by the accumulation of toxic substances (toxins) in the body. (UROD UROD Ultra-Rapid Opiate Detoxification (R)) treatment method. "We are pleased to add the UROD treatment method as an option for our patients and community," said Grant Hospital CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Celeste Celeste is a woman's first name. Celeste may also refer to: in Music
UROD(R) is the only clinically tested and effective treatment method to rapidly detoxify de·tox·i·fy v. 1. To counteract or destroy the toxic properties of a substance. 2. To remove the effects of poison from something, such as the blood. 3. individuals addicted to opiate-based drugs, including heroin -- within four to six hours with little or no withdrawal symptoms. The treatment provides a safe and humane detoxification approach for patients, making it a far less painful recovery process than currently offered alternatives. This approach significantly enhances motivation for individuals who wish to overcome addiction. CITA also offers a comprehensive, continuing care program -- FIT(SM) (Flexible Intensity Treatment). After the UROD procedure, the patient embarks on a six-month medication and on-going therapy regimen. The aftercare af·ter·care n. Follow-up care provided after a medical procedure or treatment program. aftercare the care and treatment of a convalescent patient, especially one that has undergone surgery. medication works by blocking opiate receptors in the central nervous system, allowing for continued repair and regeneration. Unlike alternative processes, the medication used in the FIT process is not a substitute for heroin or other opiates Opiates Analgesic, pain killing drugs, such as heroin and morphine that depress the central nervous system. Mentioned in: Withdrawal Syndromes , and creates no further dependency. In fact, while on the aftercare medication, if a patient uses opiates again, the euphoric "high" is not experienced. In addition to general therapy-related services, a key component of its continuing care program is www.CubeCentral.com. -- CITA's Web-based community portal. The portal was created to provide a host of products, support and services designed to aid addicts and recovering addicts, as well as family, friends and professionals, who may be affected by addiction and addiction recovery. The UROD(R) Method has been featured in the storylines of popular television programs, such as ER, Chicago Hope and General Hospital and previewed on ABC's 20/20, Fox News, Discover Wall Street and World Business Review. About Grant Hospital Founded in 1883, Grant Hospital is located in Chicago's Lincoln Park neighborhood and has served the health care needs of the surrounding communities for more than a century. Grant was one of the first hospitals in the city of Chicago to offer addiction services and has been a leader in the treatment of chemical dependency for more than 30 years. About CITA Biomedical CITA Biomedical Inc., headquartered in Beverly Hills, Calif., focuses on investigation and treatment of addiction. The company grows its business through internal expansion and seeks compatible, competitive and complementing technologies and acquisitions to enhance its corporate portfolio. CITA Biomedical Inc. has two operating divisions: CITA Americas Inc. and CubeCentral.com Inc. For more information, visit www.citabio.com. UROD is a registered trademark of CITA Biomedical Inc. FIT is a service mark of CITA Biomedical Inc. The information contained in this press release includes forward-looking statements. Forward-looking statements include declarations concerning plans, objectives, goals, strategies, future events and/or performance, and underlying assumptions and other statements which are other than statements of historical facts. Forward-looking statements usually contain the words "estimate," "anticipate," "believe," "expect" and other similar expressions that involve risks and uncertainties. These risks and uncertainties include, but are not limited to, the Company's status as a start-up enterprise with uncertain profitability, its need for significant capital, limited facilities, competition, uncertainty as to market acceptance of its services, and the protection of its intellectual property. The Company's actual results could differ materially from those expressed or implied in any forward-looking statements. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion